Eqis Capital Management Inc. Has $1.15 Million Position in Walgreens Boots Alliance Inc (WBA)
Eqis Capital Management Inc. boosted its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 11.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,824 shares of the pharmacy operator’s stock after purchasing an additional 1,533 shares during the period. Eqis Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $1,145,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in WBA. Hefty Wealth Partners lifted its stake in Walgreens Boots Alliance by 5,097.8% in the third quarter. Hefty Wealth Partners now owns 9,616 shares of the pharmacy operator’s stock valued at $743,000 after acquiring an additional 9,431 shares during the last quarter. Perpetual Ltd lifted its stake in Walgreens Boots Alliance by 22.4% in the second quarter. Perpetual Ltd now owns 6,552 shares of the pharmacy operator’s stock valued at $513,000 after acquiring an additional 1,200 shares during the last quarter. MPS Loria Financial Planners LLC acquired a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth about $457,000. Davidson Kempner Capital Management LP acquired a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth about $13,701,000. Finally, Burgundy Asset Management Ltd. lifted its stake in shares of Walgreens Boots Alliance by 5.0% during the 2nd quarter. Burgundy Asset Management Ltd. now owns 5,441,307 shares of the pharmacy operator’s stock worth $426,109,000 after buying an additional 260,756 shares during the last quarter. 60.24% of the stock is owned by institutional investors and hedge funds.
Walgreens Boots Alliance Inc (WBA) opened at $71.05 on Thursday. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance Inc has a 1-year low of $63.82 and a 1-year high of $88.00. The company has a market cap of $69,503.16, a PE ratio of 13.76, a price-to-earnings-growth ratio of 1.25 and a beta of 1.22.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. During the same period last year, the firm earned $1.07 EPS. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. equities research analysts predict that Walgreens Boots Alliance Inc will post 5.55 earnings per share for the current year.
Walgreens Boots Alliance declared that its board has approved a stock repurchase plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.25%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John Anthony Lederer bought 20,000 shares of the firm’s stock in a transaction on Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the acquisition, the director now owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is owned by company insiders.
WBA has been the subject of a number of research reports. Morgan Stanley cut shares of Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $95.00 to $85.00 in a research note on Friday, October 6th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, November 10th. Robert W. Baird restated an “outperform” rating and set a $80.00 target price (down previously from $90.00) on shares of Walgreens Boots Alliance in a research note on Thursday, October 19th. They noted that the move was a valuation call. Citigroup cut their target price on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday, November 2nd. Finally, Zacks Investment Research cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, October 17th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have given a buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Buy” and a consensus target price of $86.47.
ILLEGAL ACTIVITY NOTICE: This report was posted by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.watchlistnews.com/eqis-capital-management-inc-has-1-15-million-position-in-walgreens-boots-alliance-inc-wba/1749323.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.